• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Stryker opens new 3D printing facility in Ireland

Stryker opens new 3D printing facility in Ireland

August 3, 2022 By Sean Whooley

Stryker Ireland 3d printing facility opening
[Image from IDA]
Stryker (NYSE:SYK) announced today that it officially opened a new, high-tech facility in the Anngrove neighborhood of County Cork, Ireland.

The new, 156,000-square-foot 3D printing facility will bring 600 jobs to the area and will help Stryker advance its leadership position in additive manufacturing.

Kalamazoo, Michigan-based Stryker said in a news release that it has made significant investments in Anngrove and will continue to invest for growth. Taoiseach Micheál Martin and Ireland’s Industrial Development Agency (IDA) and other local guests were in attendance for the opening.

“I am delighted to be at the opening of Stryker’s newly expanded Anngrove facility, a very welcome development for Cork and the South West region,” Martin said in the release. “Today’s opening and announcement of the capacity for new jobs is testament to the capability, dedication and vision of the Stryker team, and of the growth and success of Stryker here. Government will work to ensure Ireland continues to be an attractive location for the med-tech sector, and business in general, supported by our highly-skilled and talented workforce.”

Stryker’s additive manufacturing for healthcare innovation includes products for treating bone-related conditions across the knees, hips, shoulders, ankles, craniomaxillofacial and spine, as well as patient-specific solutions for people who have significant disease progression, often with no alternative.

Anngrove also represents the home of the worldwide headquarters for the AMagine Institute, a center of excellence for additive manufacturing across Stryker. The institute develops breakthrough technologies and deploys them across its full portfolio of products and services, IDA said.

“The new facility and talent will continue to unlock new opportunities that were previously not possible, accelerate innovation globally and further support our mission to make healthcare better together with our customers,” said Viju Menon, group president for global quality and operations at Stryker.. “With our experience and proprietary technology, we are excited to impact more patients and drive growth with this additional investment. We are also pleased to expand our talent base in Ireland with engaging roles across a range of disciplines. At Stryker we are committed to a diverse, safe and inclusive work environment.”

IDA Ireland CEO Martin Shanahan added that Stryker, which opened its Anngrove facility in 2016, will use the expansion of the facility as recognition of the “strong ecosystem of universities, engineering talent and partners” in the country.

“[The facility] also builds on Stryker’s outstanding track record for innovation and shows the key role Anngrove plays in the company’s global additive technology research and development,” Shanahan said. “We welcome this exciting development in Anngrove, the potential it brings for future high-tech job growth, and look forward to continued success for Stryker in Ireland.”

Filed Under: Business/Financial News, Health Technology, Orthopedics Tagged With: Ireland, Stryker

More recent news

  • Zimmer Biomet, Think Surgical extend exclusive distribution agreement
  • Cambridge Heartwear inks £184M deal to supply NHS with portable ECG monitors
  • J&J, Smith+Nephew plans for ortho megamerger reportedly fall through
  • California and Massachusetts still reign as top US medtech headquarters locations
  • Teleflex wins Breakthrough Device designation for Freesolve resorbable scaffold

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy